0000950170-24-026472.txt : 20240305 0000950170-24-026472.hdr.sgml : 20240305 20240305181608 ACCESSION NUMBER: 0000950170-24-026472 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TOBIN JAMES R CENTRAL INDEX KEY: 0001190128 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 24723060 MAIL ADDRESS: STREET 1: C/O CURIS INC STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 4 1 ownership.xml 4 X0508 4 2024-03-01 0001756262 TransMedics Group, Inc. TMDX 0001190128 TOBIN JAMES R C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD ANDOVER MA 01810 true false false false true Common Stock 2024-03-01 4 S false 200 81.41 D 233391 I By the James R. Tobin 2012 Trust Common Stock 2024-03-01 4 S false 4234 82.84 D 229157 I By the James R. Tobin 2012 Trust Common Stock 2024-03-01 4 S false 5746 83.63 D 223411 I By the James R. Tobin 2012 Trust Common Stock 2024-03-01 4 S false 2900 84.74 D 220511 I By the James R. Tobin 2012 Trust Common Stock 2024-03-01 4 S false 300 85.48 D 220211 I By the James R. Tobin 2012 Trust Common Stock 1193 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.25 to $83.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $83.26 to $84.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $84.28 to $85.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $85.39 to $85.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. By: /s/ Stephen Gordon, Attorney-in-Fact 2024-03-05